| RS1908140880 |
SOX9
|
Health Risk |
Pathogenic |
— |
| RS1908142392 |
SOX9
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1908142618 |
SOX9
|
Health Risk |
Likely pathogenic |
Camptomelic dysplasia, Camptomelic dysplasia |
| RS190814667 |
PIEZO1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS190814774 |
LTBP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Glaucoma 3, primary congenital |
| RS1908204839 |
SOX9
|
Health Risk |
Pathogenic |
— |
| RS1908300748 |
AFG3L2
|
Health Risk |
Pathogenic |
Optic atrophy 12, Spastic paraparesis |
| RS190830121 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1908307291 |
B9D1
|
Health Risk |
Pathogenic |
Meckel-Gruber syndrome, Joubert syndrome |
| RS1908309088 |
AFG3L2
|
Health Risk |
Pathogenic |
Intellectual disability, Optic atrophy |
| RS190835338 |
ADGRV1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1908369114 |
AFG3L2
|
Health Risk |
Pathogenic |
Optic atrophy, Reduced tendon reflexes |
| RS1908371616 |
AFG3L2
|
Health Risk |
Likely pathogenic |
Sensorineural hearing loss disorder, Optic atrophy |
| RS190841442 |
FGF23
|
Health Risk |
Conflicting classifications of pathogenicity |
Tumoral calcinosis, hyperphosphatemic |
| RS190841601 |
SETX
|
Health Risk |
Conflicting classifications of pathogenicity |
Amyotrophic lateral sclerosis type 4, Spinocerebellar ataxia |
| RS1908507433 |
AFG3L2
|
Health Risk |
Pathogenic |
Optic atrophy, Optic atrophy |
| RS1908508905 |
SCN4A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperkalemic periodic paralysis, Hyperkalemic periodic paralysis |
| RS190853081 |
APOE
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Alzheimer disease 2 |
| RS190853310 |
SCN4A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperkalemic periodic paralysis, Hyperkalemic periodic paralysis |
| RS190853693 |
SAG
|
Health Risk |
Conflicting classifications of pathogenicity |
Oguchi disease, Retinitis pigmentosa |
| RS190854744 |
AHI1
|
Health Risk |
Conflicting classifications of pathogenicity |
Joubert syndrome, Joubert syndrome |
| RS1908566777 |
AFG3L2
|
Health Risk |
Likely pathogenic |
Optic atrophy 12, Optic atrophy 12 |
| RS1908593639 |
SCN4A
|
Health Risk |
Likely pathogenic |
Hyperkalemic periodic paralysis, Hyperkalemic periodic paralysis |
| RS1908594231 |
SCN4A
|
Health Risk |
Likely pathogenic |
Hyperkalemic periodic paralysis, Hyperkalemic periodic paralysis |
| RS1908668408 |
SCN4A
|
Health Risk |
Likely pathogenic |
Congenital myasthenic syndrome 16, Congenital myasthenic syndrome 16 |
| RS190867604 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy 4, autosomal dominant |
| RS190867671 |
BCKDHB
|
Health Risk |
Pathogenic |
Maple syrup urine disease, Maple syrup urine disease type 1A |
| RS190868473 |
DRP2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1908688683 |
SCN4A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperkalemic periodic paralysis, Hyperkalemic periodic paralysis |
| RS1908691206 |
SCN4A
|
Health Risk |
Likely pathogenic |
SCN4A-related non-dystrophic myotonia, SCN4A-related non-dystrophic myotonia |
| RS1908762801 |
CHRNB1
|
Health Risk |
Likely pathogenic |
Congenital myasthenic syndrome 2A, Congenital myasthenic syndrome 2A |
| RS190876509 |
AAAS
|
Health Risk |
Conflicting classifications of pathogenicity |
Glucocorticoid deficiency with achalasia, Glucocorticoid deficiency with achalasia |
| RS190878719 |
TGFBR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, Loeys-Dietz syndrome |
| RS190881240 |
ADAR
|
Health Risk |
Conflicting classifications of pathogenicity |
Symmetrical dyschromatosis of extremities, Aicardi-Goutieres syndrome 6 |
| RS190885103 |
OPA3
|
Health Risk |
Conflicting classifications of pathogenicity |
Optic atrophy 3, 3-Methylglutaconic aciduria type 3 |
| RS190887679 |
AIPL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Leber congenital amaurosis 4, Leber congenital amaurosis 4 |
| RS1908916380 |
SCN4A
|
Health Risk |
Pathogenic |
Hyperkalemic periodic paralysis, Hyperkalemic periodic paralysis |
| RS1908920447 |
ITGA3
|
Health Risk |
Likely pathogenic |
— |
| RS1908964770 |
B9D1
|
Health Risk |
Likely pathogenic |
Joubert syndrome, Meckel-Gruber syndrome |
| RS190897143 |
KCNJ10
|
Health Risk |
Conflicting classifications of pathogenicity |
EAST syndrome, Autosomal recessive nonsyndromic hearing loss 4 |
| RS190897990 |
KRT4
|
Health Risk |
Conflicting classifications of pathogenicity |
White sponge nevus 1, Inborn genetic diseases |
| RS1908992563 |
CHRNB1
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital myasthenic syndrome 2A, Congenital myasthenic syndrome 2A |
| RS1908994498 |
CHRNB1
|
Health Risk |
Pathogenic |
Congenital myasthenic syndrome 2A, Congenital myasthenic syndrome 2A |
| RS190900560 |
XRCC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1909032484 |
APRT
|
Health Risk |
Pathogenic |
Adenine phosphoribosyltransferase deficiency, Adenine phosphoribosyltransferase deficiency |
| RS190903270 |
USP53
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, USP53-related disorder |
| RS1909033869 |
APRT
|
Health Risk |
Pathogenic |
Adenine phosphoribosyltransferase deficiency, Adenine phosphoribosyltransferase deficiency |
| RS1909034163 |
APRT
|
Health Risk |
Pathogenic |
Adenine phosphoribosyltransferase deficiency, Adenine phosphoribosyltransferase deficiency |
| RS1909035155 |
APRT
|
Health Risk |
Pathogenic |
Adenine phosphoribosyltransferase deficiency, Adenine phosphoribosyltransferase deficiency |
| RS1909037144 |
APRT
|
Health Risk |
Pathogenic |
Adenine phosphoribosyltransferase deficiency, Adenine phosphoribosyltransferase deficiency |
| RS1909038050 |
APRT
|
Health Risk |
Pathogenic |
Adenine phosphoribosyltransferase deficiency, Adenine phosphoribosyltransferase deficiency |
| RS1909040577 |
APRT
|
Health Risk |
Pathogenic |
Adenine phosphoribosyltransferase deficiency, Adenine phosphoribosyltransferase deficiency |
| RS1909055310 |
APRT
|
Health Risk |
Pathogenic |
Adenine phosphoribosyltransferase deficiency, Adenine phosphoribosyltransferase deficiency |
| RS1909055807 |
APRT
|
Health Risk |
Pathogenic |
Adenine phosphoribosyltransferase deficiency, Adenine phosphoribosyltransferase deficiency |
| RS1909056519 |
APRT
|
Health Risk |
Likely pathogenic |
Adenine phosphoribosyltransferase deficiency, Adenine phosphoribosyltransferase deficiency |
| RS1909057323 |
APRT
|
Health Risk |
Pathogenic |
Adenine phosphoribosyltransferase deficiency, Adenine phosphoribosyltransferase deficiency |
| RS1909057938 |
APRT
|
Health Risk |
Pathogenic |
Adenine phosphoribosyltransferase deficiency, Adenine phosphoribosyltransferase deficiency |
| RS190906444 |
ZCCHC12
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS190906755 |
CDHR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cone-rod dystrophy 15, CDHR1-related disorder |
| RS1909078308 |
APRT
|
Health Risk |
Pathogenic |
Adenine phosphoribosyltransferase deficiency, Adenine phosphoribosyltransferase deficiency |
| RS1909079256 |
APRT
|
Health Risk |
Pathogenic |
Adenine phosphoribosyltransferase deficiency, Adenine phosphoribosyltransferase deficiency |
| RS1909079392 |
PMP22
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease, Charcot-Marie-Tooth disease |
| RS1909088511 |
APRT
|
Health Risk |
Pathogenic |
Adenine phosphoribosyltransferase deficiency, Adenine phosphoribosyltransferase deficiency |
| RS1909091672 |
APRT
|
Health Risk |
Likely pathogenic |
Adenine phosphoribosyltransferase deficiency, Adenine phosphoribosyltransferase deficiency |
| RS190909610 |
PRPF8
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS190910161 |
ARX
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 1 |
| RS190910346 |
CNGB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS190912679 |
COL5A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, classic type |
| RS1909137923 |
APRT
|
Health Risk |
Pathogenic |
Adenine phosphoribosyltransferase deficiency, Adenine phosphoribosyltransferase deficiency |
| RS1909139691 |
APRT
|
Health Risk |
Pathogenic |
Adenine phosphoribosyltransferase deficiency, Adenine phosphoribosyltransferase deficiency |
| RS1909144433 |
APRT
|
Health Risk |
Pathogenic |
Adenine phosphoribosyltransferase deficiency, Adenine phosphoribosyltransferase deficiency |
| RS1909145179 |
APRT
|
Health Risk |
Pathogenic |
— |
| RS1909145695 |
APRT
|
Health Risk |
Pathogenic |
Adenine phosphoribosyltransferase deficiency, Adenine phosphoribosyltransferase deficiency |
| RS1909147057 |
APRT
|
Health Risk |
Pathogenic |
Adenine phosphoribosyltransferase deficiency, Adenine phosphoribosyltransferase deficiency |
| RS190914906 |
TG
|
Health Risk |
Conflicting classifications of pathogenicity |
Iodotyrosyl coupling defect, Iodotyrosyl coupling defect |
| RS1909160707 |
APRT
|
Health Risk |
Likely pathogenic |
Adenine phosphoribosyltransferase deficiency, Adenine phosphoribosyltransferase deficiency |
| RS190916587 |
LHX3
|
Health Risk |
Conflicting classifications of pathogenicity |
Non-acquired combined pituitary hormone deficiency with spine abnormalities, Non-acquired combined pituitary hormone deficiency with spine abnormalities |
| RS190917891 |
COL12A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ullrich congenital muscular dystrophy 2, Bethlem myopathy 2 |
| RS190921137 |
GALC
|
Health Risk |
Conflicting classifications of pathogenicity |
Galactosylceramide beta-galactosidase deficiency, GALC-related disorder |
| RS190922596 |
ADGRV1
|
Health Risk |
Conflicting classifications of pathogenicity |
Febrile seizures, familial |
| RS1909238157 |
PMP22
|
Health Risk |
Likely pathogenic |
— |
| RS1909238801 |
PMP22
|
Health Risk |
Likely pathogenic |
— |
| RS1909244614 |
PMP22
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease, type I |
| RS1909248652 |
PMP22
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease, type I |
| RS190925009 |
TET3
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS190928557 |
ZNF469
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Brittle cornea syndrome 1 |
| RS190929421 |
KMT2B
|
Health Risk |
Conflicting classifications of pathogenicity |
Kabuki syndrome 1, Kabuki syndrome 1 |
| RS190935424 |
SGCD
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Autosomal recessive limb-girdle muscular dystrophy type 2F |
| RS1909376846 |
SCN4A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperkalemic periodic paralysis, Hyperkalemic periodic paralysis |
| RS190938950 |
PIEZO2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS190940697 |
NPHP4
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephronophthisis, Nephronophthisis 4 |
| RS1909453191 |
SCN4A
|
Health Risk |
Likely pathogenic |
Hyperkalemic periodic paralysis, Hyperkalemic periodic paralysis |
| RS190947144 |
ENPP1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1909497237 |
CDH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1909519361 |
SCN4A
|
Health Risk |
Likely pathogenic |
Hyperkalemic periodic paralysis, Hyperkalemic periodic paralysis |
| RS1909527513 |
SUZ12
|
Health Risk |
Pathogenic/Likely pathogenic |
Acute megakaryoblastic leukemia in down syndrome, Acute megakaryoblastic leukemia in down syndrome |
| RS1909531869 |
ATP8B1
|
Health Risk |
Pathogenic |
— |
| RS1909534341 |
ATP8B1
|
Health Risk |
Likely pathogenic |
Benign recurrent intrahepatic cholestasis type 1, Benign recurrent intrahepatic cholestasis type 1 |
| RS1909551923 |
TNFRSF11A
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1909571836 |
SMAD4
|
Health Risk |
Pathogenic |
Juvenile polyposis syndrome, Juvenile polyposis syndrome |